METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE
Approval overview METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 202870 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE Form and strength TABLET;ORAL - 50MG;100MG Sponsor ALEMBIC Submission history Latest submission status date: 2024-05-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 202870 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient HYDROCHLOROTHIAZIDE; METOPROLOL TARTRATE Form and strength TABLET;ORAL - 50MG;100MG Sponsor ALEMBIC Submission history Latest submission status date: 2024-05-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.